Because activation of the Akt–mTOR oncogenic signaling is required for BRAFV600E-induced melanomagenesis26, we further studied whether the cooperation of PHD2 deletion and BRAFV600E is sufficient to trigger melanoma formation. This evidence concerns the gene EGLN1 and melanoma.